Novo Nordisk NVO shares have lost 15.2% so far this month compared with the industry’s decline of 4.6%. The company has also underperformed in the sector and the S&P 500 during the same time ...

Novo Nordisk announced Monday a $2 billion deal with a Chinese company making a drug in the same GLP-1 space where the Danish company is currently the leading player. Novo Nordisk said it’s ...

Novo Nordisk is expanding discounted sales of its Wegovy weight loss drug. Novo Nordisk is also licensing a new weight loss drug from China. Crunching the data, the news looks relatively worse for ...

The report highlighted that Novo Nordisk currently charges Americans $969 a month for diabetes therapy Ozempic, but just $155 in Canada and $59 in Germany. Similarly, the list price for obesity ...

Pharmaceutical manufacturer Novo Nordisk on Wednesday announced it will be offering a direct-to-patient program for uninsured and underinsured individuals to be able to pay cash for its weight ...

Shares of Novo Nordisk slipped in Monday morning trading after the company announced results of its latest weight-loss drug trial. Novo's results from its Redefine 2 late-stage trial of ...

the Senate Health Committee grilled Novo Nordisk CEO Lars Fruergaard Jørgensen over why Wegovy and Ozempic cost hundreds of dollars less per month in countries such as France, Canada and Germany.

The German software company's share price gained 40% in the past year, while Danish drugmaker Novo Nordisk has gradually lost ...

Novo Nordisk shares rallied on Tuesday as a maker of a weight-loss drug alternative confirmed it won’t be selling it for much longer. Hims & Hers Health Inc.’s stock plunged last week when the ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE ... He agreed to a 30-day pause on tariffs on Mexico and Canada in return for the two countries bolstering border ...

Novo Nordisk stock has fallen roughly 40% from a peak it reached last June. The U.S. Food and Drug Administration recently confirmed Novo Nordisk is producing enough Ozempic and Wegovy to meet demand.

He agreed to a 30-day pause on tariffs on Mexico and Canada in return for the two ... by 218 percentage points (see more details here). Novo Nordisk A/S (NYSE:NVO) is a global healthcare company ...